This is not an exception, alas.May following pasuk only speak about a very small part of the medical establishment of today, hopefully…..

12  When Hashem saw how corrupt the earth was, for all flesh had 

corrupted its ways on earth,

יב  וַיַּרְא אֱלֹהִים אֶת־הָאָרֶץ וְהִנֵּה נִשְׁחָתָה כִּי־הִשְׁחִית כָּל־בָּשָׂר אֶת־דַּרְכּוֹ עַל־הָאָרֶץ׃

The company that made Neurontin, Parke-Davis, was a subsidiary of Warner-Lambert, which eventually got bought by Pfizer. Per 800 pages of documents that have been made public through lawsuits, it’s clear how gabapentin was pushed on doctors: Parke-Davis rated doctors by the dollar value of the prescriptions they could potentially write. They zeroed in on doctors who were influential and affiliated with major medical centers, who they thought could encourage their colleagues to use gabapentin too. The company wrote in their internal documents from the mid 1990s that this strategy would be “one of the most effective ways to communicate our message.” (The documents are in the Drug Industry Document Archive at the University of California San Francisco Library.)

Parke-Davis hired medical education companies to write review papers, original articles, and letters to the editor in medical journals about gabapentin for “$13,375 to $18,000 per article,” plus a $1,000 honorarium for the author. The majority of these articles had “favorable” conclusions about gabapentin, and in most instances the payments were not disclosed.

One placebo-controlled study was delayed because it found that there was no effect on the primary outcome, which was neuropathic pain. Documents showed that the company held the study because “[Parke–Davis employees] should take care not to publish anything that damages neurontin’s marketing success.”

prpgabapentin prpmedicalcorruption